SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-016325
Filing Date
2023-01-26
Accepted
2023-01-26 17:01:06
Documents
12
Period of Report
2023-01-20
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K d488601d8k.htm   iXBRL 8-K 28869
  Complete submission text file 0001193125-23-016325.txt   152392

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cfrx-20230120.xsd EX-101.SCH 2859
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cfrx-20230120_lab.xml EX-101.LAB 17994
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cfrx-20230120_pre.xml EX-101.PRE 11267
6 EXTRACTED XBRL INSTANCE DOCUMENT d488601d8k_htm.xml XML 3438
Mailing Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701
Business Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701 914-207-2300
CONTRAFECT Corp (Filer) CIK: 0001478069 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36577 | Film No.: 23558489
SIC: 2834 Pharmaceutical Preparations